- Home
- STRS vs NKTX Comparison
STRS vs NKTX Comparison
Compare STRS & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRS
- NKTX
- Stock Information
- Founded
- STRS 1992
- NKTX 2015
- Country
- STRS United States
- NKTX United States
- Employees
- STRS N/A
- NKTX N/A
- Industry
- STRS Homebuilding
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- STRS Real Estate
- NKTX Health Care
- Exchange
- STRS Nasdaq
- NKTX Nasdaq
- Market Cap
- STRS 150.3M
- NKTX 147.7M
- IPO Year
- STRS N/A
- NKTX 2020
- Fundamental
- Price
- STRS $18.90
- NKTX $1.79
- Analyst Decision
- STRS
- NKTX Strong Buy
- Analyst Count
- STRS 0
- NKTX 5
- Target Price
- STRS N/A
- NKTX $13.25
- AVG Volume (30 Days)
- STRS 6.1K
- NKTX 873.0K
- Earning Date
- STRS 11-12-2025
- NKTX 11-10-2025
- Dividend Yield
- STRS N/A
- NKTX N/A
- EPS Growth
- STRS N/A
- NKTX N/A
- EPS
- STRS N/A
- NKTX N/A
- Revenue
- STRS $31,912,000.00
- NKTX N/A
- Revenue This Year
- STRS N/A
- NKTX N/A
- Revenue Next Year
- STRS N/A
- NKTX N/A
- P/E Ratio
- STRS N/A
- NKTX N/A
- Revenue Growth
- STRS N/A
- NKTX N/A
- 52 Week Low
- STRS $15.10
- NKTX $1.31
- 52 Week High
- STRS $27.00
- NKTX $3.16
- Technical
- Relative Strength Index (RSI)
- STRS 61.26
- NKTX 37.25
- Support Level
- STRS $18.60
- NKTX $1.85
- Resistance Level
- STRS $19.19
- NKTX $1.85
- Average True Range (ATR)
- STRS 0.42
- NKTX 0.10
- MACD
- STRS 0.13
- NKTX -0.02
- Stochastic Oscillator
- STRS 100.00
- NKTX 26.76
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.